Latest news
Neuren Pharmaceuticals (ASX:NEU) in Focus on Biotech Progress - kalkinemedia.comkalkinemedia.com · Fri, 07 Aug 2026 10:09:00 GMTNeuren Pharmaceuticals (ASX:NEU) Is Up 26.3% After Record DAYBUE Sales and Upgraded 2026 Royalties - simplywall.stsimplywall.st · Thu, 06 Aug 2026 06:42:42 GMTNeuren Pharmaceuticals (ASX:NEU) in Focus: What Investors Are Watching After a Positive Session? - KalkineKalkine · Thu, 06 Aug 2026 02:40:00 GMTChartWatch ASX Scans: BHP, Macquarie, Ansell, Echoiq, EQ Resources, Flight Centre, Neuren Pharmaceuticals, Starpharma - Market IndexMarket Index · Wed, 05 Aug 2026 23:21:29 GMTAre Neuren Pharmaceuticals shares a buy, hold or sell after rocketing 16%? - The Motley Fool AustraliaThe Motley Fool Australia · Wed, 05 Aug 2026 20:34:42 GMTNeuren Pharma Shares Jump 16% to Lead ASX 200: The Latest - thebull.com.authebull.com.au · Wed, 05 Aug 2026 09:58:07 GMTNeuren Pharmaceuticals (ASX:NEU) Soars on Record DAYBUE Sales and Upgraded Royalty Forecast - KalkineKalkine · Wed, 05 Aug 2026 08:06:00 GMTNEU:ASX Announcement - Record Q2 DAYBUE net sales of US$125m, CY26 royalty upgraded - 05 Aug 2026 - Market IndexMarket Index · Wed, 05 Aug 2026 04:11:25 GMT